MedTrace Logo

Hydrolized Protein Formula for Premature Infants

NCT01156493 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2017-05-10

No results posted yet for this study

Summary

Premature infants fed with a protein hydrolyzed formula will have better tolerance needing shorter time to achieve full feeds when compared to those fed with an intact protein formula.

Conditions

  • Prematurity

Interventions

OTHER

Protein Hydrolyzed Premature Formula

Infants will be fed with a protein hydrolyzed premature formula until they reach full feeds

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Teresa Del Moral, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Days
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2013-10-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156493 on ClinicalTrials.gov